Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
1999 2
2000 6
2001 1
2002 2
2003 3
2004 1
2005 2
2006 1
2007 3
2008 5
2010 3
2011 1
2012 1
2015 3
2016 2
2017 2
2018 1
2019 2
2020 6
2021 3
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Bladé J, Moreau P; PERSEUS Trial Investigators. Sonneveld P, et al. N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12. N Engl J Med. 2024. PMID: 38084760 Clinical Trial.
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Mina R, Musto P, Rota-Scalabrini D, Paris L, Gamberi B, Palmas A, Aquino S, de Fabritiis P, Giuliani N, De Rosa L, Gozzetti A, Cellini C, Bertamini L, Capra A, Oddolo D, Vincelli ID, Ronconi S, Pavone V, Pescosta N, Cea M, Fioritoni F, Ballanti S, Grasso M, Zamagni E, Belotti A, Boccadoro M, Gay F. Mina R, et al. Among authors: ronconi s. Lancet Oncol. 2023 Jan;24(1):64-76. doi: 10.1016/S1470-2045(22)00693-3. Epub 2022 Dec 14. Lancet Oncol. 2023. PMID: 36528035 Clinical Trial.
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.
D'Agostino M, Bertuglia G, Rota-Scalabrini D, Belotti A, Morè S, Corradini P, Oliva S, Ledda A, Grasso M, Pavone V, Ronconi S, Vincelli ID, Ballanti S, Velluti C, Cellini C, Gozzetti A, Palmas AD, Gamberi B, Mancuso K, Paris L, Zambello R, Petrucci MT, Bruno B, Musto P, Gay F. D'Agostino M, et al. Among authors: ronconi s. Blood. 2024 Feb 15;143(7):592-596. doi: 10.1182/blood.2023022080. Blood. 2024. PMID: 38048557
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Martino M, Canale FA, Alati C, Vincelli ID, Moscato T, Porto G, Loteta B, Naso V, Mazza M, Nicolini F, Ghelli Luserna di Rorà A, Simonetti G, Ronconi S, Ceccolini M, Musuraca G, Martinelli G, Cerchione C. Martino M, et al. Among authors: ronconi s. Cancers (Basel). 2021 May 27;13(11):2639. doi: 10.3390/cancers13112639. Cancers (Basel). 2021. PMID: 34072068 Free PMC article. Review.
Secondary lung tumors in hematological patients.
Amadori D, Ronconi S. Amadori D, et al. Among authors: ronconi s. Semin Respir Crit Care Med. 2005 Oct;26(5):520-6. doi: 10.1055/s-2005-922035. Semin Respir Crit Care Med. 2005. PMID: 16267703 Review.
An immunotherapy-induced plasma cell leukaemoid reaction.
Massari E, Rosetti M, Poletti G, Ronconi S, Dorizzi RM. Massari E, et al. Among authors: ronconi s. Br J Haematol. 2020 Mar;188(6):813. doi: 10.1111/bjh.16394. Epub 2020 Jan 23. Br J Haematol. 2020. PMID: 31975380 Free article. No abstract available.
Thermodynamic features of dioxins' adsorption.
Prisciandaro M, Piemonte V, di Celso GM, Ronconi S, Capocelli M. Prisciandaro M, et al. Among authors: ronconi s. J Hazard Mater. 2017 Feb 15;324(Pt B):645-652. doi: 10.1016/j.jhazmat.2016.11.038. Epub 2016 Nov 14. J Hazard Mater. 2017. PMID: 27866764
Clinical outcome of extramedullary plasmacytoma.
Galieni P, Cavo M, Pulsoni A, Avvisati G, Bigazzi C, Neri S, Caliceti U, Benni M, Ronconi S, Lauria F. Galieni P, et al. Among authors: ronconi s. Haematologica. 2000 Jan;85(1):47-51. Haematologica. 2000. PMID: 10629591
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes.
Pallotti MC, Rossi R, Scarpi E, Dall'Agata M, Ricci M, Ceccolini M, Ronconi S, Valenti V, Maltoni M, Martinelli G, Cerchione C. Pallotti MC, et al. Among authors: ronconi s. Support Care Cancer. 2022 Mar;30(3):2293-2298. doi: 10.1007/s00520-021-06560-8. Epub 2021 Oct 31. Support Care Cancer. 2022. PMID: 34718886 Free PMC article.
50 results